Cargando…
Low-dose PLX5622 treatment prevents neuroinflammatory and neurocognitive sequelae after sepsis
BACKGROUND: Sepsis-associated encephalopathy (SAE) is characterized by symptoms of delirium including hallucinations, impaired concentration, agitation, or coma and is associated with poor outcome in the early phase of sepsis. In addition, sepsis survivors often suffer from persisting memory deficit...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691003/ https://www.ncbi.nlm.nih.gov/pubmed/38041192 http://dx.doi.org/10.1186/s12974-023-02975-8 |